Sarepta Therapeutics is a global biotechnology company at the forefront of precision genetic medicine, dedicated to engineering and delivering life-changing therapies for individuals affected by rare, devastating diseases. With a primary focus on Duchenne muscular dystrophy (DMD), Sarepta is advancing a robust and diverse pipeline of RNA-targeted therapeutics, gene therapy, and gene editing programs. The company's mission is driven by a commitment to patients, scientific innovation, and a relentless pursuit of treatments for diseases with limited or no therapeutic options. Sarepta strives to make a profound impact on the lives of patients and their families through groundbreaking science and a deep understanding of the patient journey.
The Cambridge headquarters serves as the central command for Sarepta's global operations, including corporate leadership, strategic decision-making, research and development oversight, and administrative functions.
Located in a modern facility, the headquarters is designed to foster innovation and collaboration. It likely includes advanced laboratory spaces, open-plan offices, and meeting areas equipped for a dynamic biotech environment.
Sarepta's Cambridge HQ fosters a mission-driven and patient-focused work culture. Employees are often described as passionate, dedicated, and collaborative, working in a fast-paced environment to advance science and bring therapies to patients in need.
Its Kendall Square location provides Sarepta with unparalleled access to a rich ecosystem of academic institutions, research talent, venture capital, and other biotech companies, fostering partnerships and innovation critical to its mission.
Sarepta Therapeutics maintains a significant global presence to support its mission of delivering precision genetic medicines worldwide. Key functions supported globally include research and development collaborations, clinical trial operations across multiple continents, manufacturing and supply chain management, regulatory affairs in various jurisdictions, and commercial operations to ensure patient access to approved therapies. Their international headquarters in Dublin, Ireland, and offices in locations like Switzerland and Japan, complement their extensive U.S. operations, enabling them to serve patients with rare diseases on a global scale.
215 First Street
Cambridge
MA
USA
Address: One Sarepta Way, Andover, MA 01810
Serves as a vital manufacturing and development hub in Massachusetts, leveraging the state's strong biomanufacturing infrastructure and talent pool.
Address: 70 Sir John Rogerson’s Quay, Dublin 2, Ireland
Manages and expands Sarepta's commercial presence and patient access initiatives outside the United States, navigating diverse regulatory and healthcare systems.
Address: 371A West Fifth Avenue, Columbus, OH 43201
Acts as a primary center for gene therapy innovation and production, benefiting from Ohio's growing prominence in the gene therapy field and proximity to research partners.
Address: Dammstrasse 19, CH-6300 Zug, Switzerland
Provides a strategic base in continental Europe, facilitating business operations and market engagement in Switzerland and surrounding countries.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Sarepta Therapeutics' leadership includes:
Sarepta Therapeutics has been backed by several prominent investors over the years, including:
Over the last 12 months (May 2023 - May 2024), Sarepta Therapeutics strengthened its executive leadership with strategic appointments, notably a new Chief Business and Strategy Officer and a new Chief Financial Officer, reflecting the company's ongoing growth and strategic evolution.
Discover the tools Sarepta Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Sarepta Therapeutics primarily utilizes the email format combining the first initial and the full last name of the employee. For example, an employee named Jane Doe would likely have an email address such as 'jdoe@sarepta.com'. This is a common and professional email structure in the corporate and biotech sectors.
[first_initial][last]@sarepta.com
Format
jdoe@sarepta.com
Example
90%
Success rate
Sarepta Therapeutics Press Release (via GlobeNewswire) • May 21, 2024
The U.S. Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) supplement for ELEVIDYS, Sarepta's gene therapy for Duchenne muscular dystrophy. The new PDUFA (Prescription Drug User Fee Act) target action date is June 21, 2024. The extension is to allow the FDA additional time to review information submitted by Sarepta, including data from the ENVISION study in older, non-ambulatory individuals with Duchenne....more
Sarepta Therapeutics Press Release (via GlobeNewswire) • May 2, 2024
Sarepta reported total revenues of $413.5 million for the first quarter of 2024, a 65% increase compared to the same period in 2023. This growth was primarily driven by strong net product revenue from its approved PMO therapies (EXONDYS 51, VYONDYS 53, AMONDYS 45) and ELEVIDYS. The company also highlighted ongoing progress in its R&D pipeline and upcoming regulatory milestones....more
Sarepta Therapeutics Press Release (via GlobeNewswire) • April 8, 2024
Sarepta announced multiple presentations at the MDA 2024 conference, showcasing data across its Duchenne muscular dystrophy portfolio. This included long-term follow-up data for ELEVIDYS, updates on next-generation exon-skipping candidates like SRP-5051 (vesleteplirsen), and insights from its gene therapy programs, underscoring its commitment to advancing treatments for DMD....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Sarepta Therapeutics, are just a search away.